Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents
作者:Anne Cecília Nascimento da Cruz、Dalci José Brondani、Temístocles I´talo de Santana、Lucas Oliveira da Silva、Elizabeth Fernanda da Oliveira Borba、Antônio Rodolfo de Faria、Julianna Ferreira Cavalcanti de Albuquerque、Sylvie Piessard、Rafael Matos Ximenes、Blandine Baratte、Stéphane Bach、Sandrine Ruchaud、Francisco Jaime Bezerra Mendonça Junior、Marc-Antoine Bazin、Marcelo Montenegro Rabello、Marcelo Zaldini Hernandes、Pascal Marchand、Teresinha Gonçalves da Silva
DOI:10.3390/ph12040169
日期:——
Fourteen arylsemicarbazone derivatives were synthesized and evaluated in order to find agents with potential anticancer activity. Cytotoxic screening was performed against K562, HL-60, MOLT-4, HEp-2, NCI-H292, HT-29 and MCF-7 tumor cell lines. Compounds 3c and 4a were active against the tested cancer cell lines, being more cytotoxic for the HL-60 cell line with IC50 values of 13.08 μM and 11.38 μM
合成并评估了十四种芳基半碳a酮衍生物,以发现具有潜在抗癌活性的药物。针对K562,HL-60,MOLT-4,HEp-2,NCI-H292,HT-29和MCF-7肿瘤细胞系进行细胞毒性筛选。化合物3c和4a对测试的癌细胞系具有活性,对HL-60细胞系具有更大的细胞毒性,IC50值分别为13.08μM和11.38μM。关于蛋白激酶抑制试验,3c抑制7种不同的激酶,4a强烈抑制CK1δ/ε激酶。研究的激酶参与多种细胞功能,例如增殖,迁移,细胞死亡和细胞周期进程。通过流式细胞仪进行的其他分析显示3c和4a引起线粒体膜去极化,表明由内在途径介导的细胞凋亡。化合物3c诱导了HL-60细胞在细胞周期的G1期停滞,在膜联蛋白V试验中,约50%的细胞在最高测试浓度(26μM)下处于凋亡状态。化合物4a通过在G1期聚集异常的有丝分裂后细胞来抑制细胞周期,并以最高浓度(22μM)诱导DNA片段化。